MACROGENICS director granted RSUs and 22,000 options
MACROGENICS INC director Federica F. O'Brien reported equity compensation and an option exercise.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MACROGENICS INC director Federica F. O'Brien reported equity compensation and an option exercise. On May 18, 2026, 3,750 restricted stock units vested and were exercised into 3,750 shares of common stock, leaving her with 14,750 common shares directly owned.
On May 19, 2026, she received a grant of 3,750 new restricted stock units and a stock option for 22,000 shares of common stock at an exercise price of $4.52 per share, expiring on May 19, 2036. The option vests in monthly 1/12th increments, while the new RSUs vest one year from grant or the day prior to the next annual meeting, if earlier. These are compensation-related awards, not open-market purchases.
Insider Trade Summary
3,750 shares exercised/converted
Exercise
4 txns
Insider
O'Brien Federica F.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 22,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 3,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 3,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,750 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 22,000 contracts (Direct);
Restricted Stock Unit — 3,750 contracts (Direct);
Common Stock — 14,750 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- F2. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.
- F3. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
- F4. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
Key Figures
RSUs vested into shares: 3,750 shares
Common shares held after vesting: 14,750 shares
New RSU grant: 3,750 units
+2 more
5 metrics
RSUs vested into shares
3,750 shares
RSUs vested and converted to common stock on May 18, 2026
Common shares held after vesting
14,750 shares
Direct MACROGENICS common stock ownership after May 18, 2026
New RSU grant
3,750 units
Restricted stock units granted on May 19, 2026
New stock option grant
22,000 shares
Stock option for MACROGENICS common stock granted May 19, 2026
Option exercise price
$4.52 per share
Exercise price of 22,000-share stock option expiring May 19, 2036
Key Terms
Restricted Stock Unit, RSUs, Stock Option (right to buy), exercise price, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSUs financial
"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.5200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual Meeting of Stockholders financial
"one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did MACROGENICS (MGNX) director Federica O'Brien report?
Federica O'Brien reported an equity grant and an option exercise. 3,750 restricted stock units vested into 3,750 common shares, and she received 3,750 new RSUs plus a 22,000-share stock option as director compensation.
What are the terms of Federica O'Brien’s new MACROGENICS stock option grant?
She received a stock option for 22,000 shares of MACROGENICS common stock at an exercise price of $4.52 per share, expiring May 19, 2036. The option vests in monthly cumulative 1/12th increments starting one month after the grant date.
When do Federica O'Brien’s new MACROGENICS restricted stock units vest?
The new restricted stock units granted to Federica O'Brien will vest one year after the grant date or on the day prior to the next annual meeting of stockholders, if that meeting occurs earlier, according to the Form 4 footnote.
Were Federica O'Brien’s MACROGENICS transactions open-market purchases or sales?
The reported activity reflects equity compensation and an option exercise, not open-market trading. RSUs vested into common shares and she received grants of new RSUs and a stock option as part of her director compensation package.
What does the RSU vesting on May 18, 2026 mean for MACROGENICS (MGNX) director ownership?
On May 18, 2026, 3,750 RSUs vested for Federica O'Brien, converting into 3,750 common shares. This increased her directly held MACROGENICS common stock to 14,750 shares, as reported in the Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
